107 related articles for article (PubMed ID: 23896707)
21. Composite diffuse large B-cell lymphoma and CD20-positive peripheral T-cell lymphoma.
Yamazaki S; Fujioka Y; Nakamura F; Ota S; Shinozaki A; Yamamoto G; Kamikubo Y; Nannya Y; Ichikawa M; Fukayama M; Kurokawa M
Pathol Int; 2011 Nov; 61(11):662-6. PubMed ID: 22029677
[TBL] [Abstract][Full Text] [Related]
22. [Case of primary malignant lymphoma of the bladder].
Goto D; Otani T; Tomioka A; Maruyama Y
Hinyokika Kiyo; 2013 Sep; 59(9):583-6. PubMed ID: 24113757
[TBL] [Abstract][Full Text] [Related]
23. [An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].
Brouillard C; Granel-Brocard F; Montagne K; Bastien C; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2011; 138(8-9):601-4. PubMed ID: 21893235
[TBL] [Abstract][Full Text] [Related]
24. Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma.
Hornberger JC; Best JH
Cancer; 2005 Apr; 103(8):1644-51. PubMed ID: 15756658
[TBL] [Abstract][Full Text] [Related]
25. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.
Sehn LH; Donaldson J; Chhanabhai M; Fitzgerald C; Gill K; Klasa R; MacPherson N; O'Reilly S; Spinelli JJ; Sutherland J; Wilson KS; Gascoyne RD; Connors JM
J Clin Oncol; 2005 Aug; 23(22):5027-33. PubMed ID: 15955905
[TBL] [Abstract][Full Text] [Related]
26. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
27. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.
Momose S; Tamaru J; Kishi H; Mikata I; Mori M; Toyozumi Y; Itoyama S
Hum Pathol; 2009 Jan; 40(1):75-82. PubMed ID: 18755494
[TBL] [Abstract][Full Text] [Related]
28. Case Study: Diffuse Large B-Cell Lymphoma Arising in Ovarian Mature Cystic Teratoma.
Maguire A; Castriciano G; Walker J; Molloy K; Quinn F; Osman N; Vandenberghe E; Jeffers M; Gaffney E; Flavin R
Int J Gynecol Pathol; 2015 Sep; 34(5):459-64. PubMed ID: 25996637
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
30. ALK-positive anaplastic large cell lymphoma with an unusual alveolar growth pattern.
Yu G; Gao Z; Huang X
Int J Clin Exp Pathol; 2014; 7(12):9086-9. PubMed ID: 25674293
[TBL] [Abstract][Full Text] [Related]
31. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting in nasal cavity: a case report and review of literature.
Chen J; Feng X; Dong M
Int J Clin Exp Pathol; 2015; 8(2):2123-30. PubMed ID: 25973114
[TBL] [Abstract][Full Text] [Related]
32. Successfully-treated mesenteric non-Hodgkin's lymphoma involving hepatic mass--a case report.
Yamaguchi T; Takahashi H; Kagawa R; Takeda R; Sakata S; Yamamoto M; Nishizaki D; Takamatsu T; Iwasa Y
Gan To Kagaku Ryoho; 2007 May; 34(5):783-7. PubMed ID: 17496458
[TBL] [Abstract][Full Text] [Related]
33. Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective.
Sehn LH; Connors JM
Oncology (Williston Park); 2005 Apr; 19(4 Suppl 1):26-34. PubMed ID: 15934515
[TBL] [Abstract][Full Text] [Related]
34. Involved-lesion radiation therapy after chemotherapy in limited-stage head-and-neck diffuse large B cell lymphoma.
Yu JI; Nam H; Ahn YC; Kim WS; Park K; Kim SJ
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):507-12. PubMed ID: 20056353
[TBL] [Abstract][Full Text] [Related]
35. [A primary malignant lymphoma of the appendix].
Shimada K; Sato M; Haruyama S; Ichikawa T; Aono G; Ohara T; Ando Y; Abe R; Nozawa Y; Wakasa H
Gan No Rinsho; 1990 Sep; 36(11):2086-91. PubMed ID: 2232177
[TBL] [Abstract][Full Text] [Related]
36. Sarcomatoid variant of B-cell lymphoma of the uterine cervix.
Kahlifa M; Buckstein R; Perez-Ordoñez B
Int J Gynecol Pathol; 2003 Jul; 22(3):289-93. PubMed ID: 12819398
[TBL] [Abstract][Full Text] [Related]
37. Bcl-2 gene expression as a predictor of outcome in diffuse large B-cell lymphoma.
Shivakumar L; Armitage JO
Clin Lymphoma Myeloma; 2006 May; 6(6):455-7. PubMed ID: 16796775
[TBL] [Abstract][Full Text] [Related]
38. Radiation therapy after R-CHOP for diffuse large B-cell lymphoma: the gain remains.
Yahalom J
J Clin Oncol; 2010 Sep; 28(27):4105-7. PubMed ID: 20713874
[No Abstract] [Full Text] [Related]
39. [Primary malignant lymphoma of the adrenal gland: a case report].
Mizusawa H; Okaneya T; Yoneyama T; Taguchi I
Hinyokika Kiyo; 1995 Dec; 41(12):991-4. PubMed ID: 8578989
[TBL] [Abstract][Full Text] [Related]
40. [Cutaneous presentation of plasmablastic lymphoma in a patient with HIV Infection].
Zaragoza V; Martínez L; Pérez-Ferriols A; Alegre V
Actas Dermosifiliogr; 2008 Dec; 99(10):820-1. PubMed ID: 19091226
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
